Clinical Trial Detail

NCT ID NCT04288687
Title A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

prostate adenocarcinoma

Therapies

Niraparib

Age Groups: senior adult

Additional content available in CKB BOOST